US 7993648
Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody
granted A61KA61K2039/505A61K2039/55522
Quick answer
US patent 7993648 (Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody) held by The Regents of the University of Colorado expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado
- Grant date
- Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 60
- CPC classes
- A61K, A61K2039/505, A61K2039/55522, A61K38/00, A61K39/12